Clinical Trial Update: A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia [Phase 1]

View source ↗

Summary

Phase 1 study to assess the safety of NNC4004-0002 in asymptomatic hyperuricemia, recruiting both healthy volunteers and individuals with elevated uric acid.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperuricemia

Drugs mentioned

• NNC4004-0002

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Healthy Volunteers, Hyperuricemia | Phase 1 | Status: RECRUITING